# Lear Corp: financial statements, quarterly

LEA · NYSE · CIK 842162 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lea.md) · [Financials](/companies/lea/financials.md) · [Filings](/companies/lea/filings.md) · [Insiders](/companies/lea/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lea/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,781](/filings/0000842162-24-000062.md) | [5,841 d](/filings/0000842162-26-000011.md) | [5,995](/filings/0000842162-25-000042.md) | [6,012](/filings/0000842162-25-000060.md) | [5,584](/filings/0000842162-25-000076.md) | [5,715 d](/filings/0000842162-26-000011.md) | [5,560](/filings/0000842162-26-000038.md) | [6,030](/filings/0000842162-26-000068.md) | [5,680](/filings/0000842162-25-000076.md) | [5,989 d](/filings/0000842162-26-000011.md) | [5,823](/filings/0000842162-26-000038.md) | [6,209](/filings/0000842162-26-000068.md) |
| Cost of revenue | $m | [5,363](/filings/0000842162-24-000062.md) | [5,436 d](/filings/0000842162-26-000011.md) | [5,597](/filings/0000842162-25-000042.md) | [5,564](/filings/0000842162-25-000060.md) | [5,179](/filings/0000842162-25-000076.md) | [5,328 d](/filings/0000842162-26-000011.md) | [5,201](/filings/0000842162-26-000038.md) | [5,591](/filings/0000842162-26-000068.md) | [5,316](/filings/0000842162-25-000076.md) | [5,646 d](/filings/0000842162-26-000011.md) | [5,373](/filings/0000842162-26-000038.md) | [5,739](/filings/0000842162-26-000068.md) |
| Gross profit | $m | not reported | not reported | [398](/filings/0000842162-25-000042.md) | [449](/filings/0000842162-25-000060.md) | [405](/filings/0000842162-25-000076.md) | [387 d](/filings/0000842162-26-000011.md) | [359](/filings/0000842162-26-000038.md) | [439](/filings/0000842162-26-000068.md) | [364](/filings/0000842162-25-000076.md) | [342 d](/filings/0000842162-26-000011.md) | [450](/filings/0000842162-26-000038.md) | [470](/filings/0000842162-26-000068.md) |
| Selling, general and administrative | $m | [183](/filings/0000842162-24-000062.md) | [173 d](/filings/0000842162-26-000011.md) | [187](/filings/0000842162-25-000042.md) | [175](/filings/0000842162-25-000060.md) | [174](/filings/0000842162-25-000076.md) | [167 d](/filings/0000842162-26-000011.md) | [172](/filings/0000842162-26-000038.md) | [186](/filings/0000842162-26-000068.md) | [166](/filings/0000842162-25-000076.md) | [183 d](/filings/0000842162-26-000011.md) | [190](/filings/0000842162-26-000038.md) | [198](/filings/0000842162-26-000068.md) |
| Operating income | $m | [220](/filings/0000842162-24-000062.md) | [218 d](/filings/0000842162-26-000011.md) | [197](/filings/0000842162-25-000042.md) | [261](/filings/0000842162-25-000060.md) | [221](/filings/0000842162-25-000076.md) | [210 d](/filings/0000842162-26-000011.md) | [182](/filings/0000842162-26-000038.md) | [248](/filings/0000842162-26-000068.md) | [193](/filings/0000842162-25-000076.md) | [155 d](/filings/0000842162-26-000011.md) | [255](/filings/0000842162-26-000038.md) | [268](/filings/0000842162-26-000068.md) |
| Interest expense | $m | [25.7](/filings/0000842162-23-000062.md) | [25.0 d](/filings/0000842162-24-000008.md) | [26.1](/filings/0000842162-24-000032.md) | [26.9](/filings/0000842162-25-000060.md) | [26.5](/filings/0000842162-25-000076.md) | [26.7 d](/filings/0000842162-26-000011.md) | [25.8](/filings/0000842162-26-000038.md) | [25.4](/filings/0000842162-26-000068.md) | [24.6](/filings/0000842162-25-000076.md) | [25.0 d](/filings/0000842162-26-000011.md) | [25.6](/filings/0000842162-26-000038.md) | [24.2](/filings/0000842162-26-000068.md) |
| Income tax | $m | [47.0](/filings/0000842162-24-000062.md) | [46.7 d](/filings/0000842162-26-000011.md) | [40.5](/filings/0000842162-25-000042.md) | [46.2](/filings/0000842162-25-000060.md) | [47.1](/filings/0000842162-25-000076.md) | [57.3 d](/filings/0000842162-26-000011.md) | [45.2](/filings/0000842162-26-000038.md) | [41.6](/filings/0000842162-26-000068.md) | [45.1](/filings/0000842162-25-000076.md) | [18.1 d](/filings/0000842162-26-000011.md) | [38.4](/filings/0000842162-26-000038.md) | [48.5](/filings/0000842162-26-000068.md) |
| Net income | $m | [133](/filings/0000842162-24-000062.md) | [127 d](/filings/0000842162-26-000011.md) | [110](/filings/0000842162-25-000042.md) | [173](/filings/0000842162-25-000060.md) | [136](/filings/0000842162-25-000076.md) | [88.1 d](/filings/0000842162-26-000011.md) | [80.7](/filings/0000842162-26-000038.md) | [165](/filings/0000842162-26-000068.md) | [108](/filings/0000842162-25-000076.md) | [82.7 d](/filings/0000842162-26-000011.md) | [172](/filings/0000842162-26-000038.md) | [193](/filings/0000842162-26-000068.md) |
| Diluted EPS | $ per share | [2.25](/filings/0000842162-24-000062.md) | not reported | [1.90](/filings/0000842162-25-000042.md) | [3.02](/filings/0000842162-25-000060.md) | [2.41](/filings/0000842162-25-000076.md) | not reported | [1.49](/filings/0000842162-26-000038.md) | [3.06](/filings/0000842162-26-000068.md) | [2.02](/filings/0000842162-25-000076.md) | not reported | [3.34](/filings/0000842162-26-000038.md) | [3.79](/filings/0000842162-26-000068.md) |
| Basic EPS | $ per share | [2.26](/filings/0000842162-24-000062.md) | not reported | [1.91](/filings/0000842162-25-000042.md) | [3.04](/filings/0000842162-25-000060.md) | [2.42](/filings/0000842162-25-000076.md) | not reported | [1.50](/filings/0000842162-26-000038.md) | [3.07](/filings/0000842162-26-000068.md) | [2.03](/filings/0000842162-25-000076.md) | not reported | [3.38](/filings/0000842162-26-000038.md) | [3.83](/filings/0000842162-26-000068.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.0](/filings/0000842162-24-000062.md) | [1.2](/filings/0000842162-26-000011.md) | [0.9](/filings/0000842162-25-000042.md) | [1.0](/filings/0000842162-25-000060.md) | [0.8](/filings/0000842162-25-000076.md) | [1.1](/filings/0000842162-26-000011.md) | [0.8](/filings/0000842162-26-000038.md) | [0.9](/filings/0000842162-26-000068.md) | [1.0](/filings/0000842162-25-000076.md) | [1.0](/filings/0000842162-26-000068.md) | [0.9](/filings/0000842162-26-000038.md) | [1.0](/filings/0000842162-26-000068.md) |
| Current assets | $bn | [7.7](/filings/0000842162-23-000062.md) | [7.6](/filings/0000842162-25-000010.md) | [7.9](/filings/0000842162-24-000032.md) | [7.8](/filings/0000842162-24-000049.md) | [7.8](/filings/0000842162-24-000062.md) | [7.2](/filings/0000842162-26-000011.md) | [7.7](/filings/0000842162-25-000042.md) | [8.2](/filings/0000842162-25-000060.md) | [8.0](/filings/0000842162-25-000076.md) | [7.7](/filings/0000842162-26-000068.md) | [8.3](/filings/0000842162-26-000038.md) | [8.4](/filings/0000842162-26-000068.md) |
| Total assets | $bn | [14.6](/filings/0000842162-24-000062.md) | [14.7](/filings/0000842162-25-000010.md) | [14.9](/filings/0000842162-25-000042.md) | [14.7](/filings/0000842162-25-000060.md) | [14.8](/filings/0000842162-25-000076.md) | [14.0](/filings/0000842162-26-000011.md) | [14.6](/filings/0000842162-26-000038.md) | [15.3](/filings/0000842162-26-000068.md) | [15.2](/filings/0000842162-25-000076.md) | [14.8](/filings/0000842162-26-000068.md) | [15.5](/filings/0000842162-26-000038.md) | [15.7](/filings/0000842162-26-000068.md) |
| Current liabilities | $bn | [5.7](/filings/0000842162-23-000062.md) | [5.7](/filings/0000842162-25-000010.md) | [5.9](/filings/0000842162-24-000032.md) | [5.8](/filings/0000842162-24-000049.md) | [5.9](/filings/0000842162-24-000062.md) | [5.4](/filings/0000842162-26-000011.md) | [5.8](/filings/0000842162-25-000042.md) | [6.1](/filings/0000842162-25-000060.md) | [5.9](/filings/0000842162-25-000076.md) | [5.7](/filings/0000842162-26-000068.md) | [6.2](/filings/0000842162-26-000038.md) | [6.4](/filings/0000842162-26-000068.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [0.0](/filings/0000842162-23-000062.md) | [0.0](/filings/0000842162-25-000010.md) | [0.0](/filings/0000842162-24-000032.md) | [0.0](/filings/0000842162-24-000049.md) | [0.0](/filings/0000842162-24-000062.md) | [0.0](/filings/0000842162-26-000011.md) | [0.0](/filings/0000842162-25-000042.md) | [0.0](/filings/0000842162-25-000060.md) | [0.0](/filings/0000842162-25-000076.md) | [0.0](/filings/0000842162-26-000068.md) | [0.0](/filings/0000842162-26-000038.md) | [0.0](/filings/0000842162-26-000068.md) |
| Shareholders' equity | $bn | [4.9](/filings/0000842162-23-000062.md) | [4.9](/filings/0000842162-25-000010.md) | [4.9](/filings/0000842162-24-000032.md) | [4.8](/filings/0000842162-24-000049.md) | [4.8](/filings/0000842162-24-000062.md) | [4.5](/filings/0000842162-26-000011.md) | [4.7](/filings/0000842162-25-000042.md) | [5.1](/filings/0000842162-25-000060.md) | [5.1](/filings/0000842162-25-000076.md) | [5.0](/filings/0000842162-26-000068.md) | [5.1](/filings/0000842162-26-000038.md) | [5.2](/filings/0000842162-26-000068.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [404 d](/filings/0000842162-24-000062.md) | [570 d](/filings/0000842162-26-000011.md) | [(34.6)](/filings/0000842162-25-000042.md) | [291 d](/filings/0000842162-25-000060.md) | [183 d](/filings/0000842162-25-000076.md) | [681 d](/filings/0000842162-26-000011.md) | [(128)](/filings/0000842162-26-000038.md) | [296 d](/filings/0000842162-26-000068.md) | [444 d](/filings/0000842162-25-000076.md) | [476 d](/filings/0000842162-26-000011.md) | [98.1](/filings/0000842162-26-000038.md) | [461 d](/filings/0000842162-26-000068.md) |
| Capital expenditure | $m | [153](/filings/0000842162-23-000062.md) | [193 d](/filings/0000842162-26-000011.md) | [114](/filings/0000842162-25-000042.md) | [121 d](/filings/0000842162-25-000060.md) | [132 d](/filings/0000842162-25-000076.md) | [192 d](/filings/0000842162-26-000011.md) | [104](/filings/0000842162-26-000038.md) | [125 d](/filings/0000842162-26-000068.md) | [137 d](/filings/0000842162-25-000076.md) | [195 d](/filings/0000842162-26-000011.md) | [125](/filings/0000842162-26-000038.md) | [173 d](/filings/0000842162-26-000068.md) |
| Dividends paid | $m | [45.2 d](/filings/0000842162-24-000062.md) | [44.6 d](/filings/0000842162-26-000011.md) | [45.5](/filings/0000842162-25-000042.md) | [43.6 d](/filings/0000842162-25-000060.md) | [42.8 d](/filings/0000842162-25-000076.md) | [41.8 d](/filings/0000842162-26-000011.md) | [43.3](/filings/0000842162-26-000038.md) | [41.2 d](/filings/0000842162-26-000068.md) | [40.9 d](/filings/0000842162-25-000076.md) | [39.4 d](/filings/0000842162-26-000011.md) | [42.5](/filings/0000842162-26-000038.md) | [38.7 d](/filings/0000842162-26-000068.md) |
| Share repurchases | $m | [84.7 d](/filings/0000842162-24-000062.md) | [159 d](/filings/0000842162-26-000011.md) | [44.6](/filings/0000842162-25-000042.md) | [62.2 d](/filings/0000842162-25-000060.md) | [204 d](/filings/0000842162-25-000076.md) | [106 d](/filings/0000842162-26-000011.md) | [25.0](/filings/0000842162-26-000038.md) | [22.5 d](/filings/0000842162-26-000068.md) | [103 d](/filings/0000842162-25-000076.md) | [175 d](/filings/0000842162-26-000011.md) | [75.0](/filings/0000842162-26-000038.md) | [100 d](/filings/0000842162-26-000068.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [59.8](/filings/0000842162-23-000062.md) | [59.6](/filings/0000842162-24-000032.md) | [59.4](/filings/0000842162-24-000049.md) | [59.1](/filings/0000842162-24-000062.md) | [57.6](/filings/0000842162-25-000042.md) | [57.2](/filings/0000842162-25-000060.md) | [56.4](/filings/0000842162-25-000076.md) | [54.2](/filings/0000842162-26-000038.md) | [54.1](/filings/0000842162-26-000068.md) | [53.7](/filings/0000842162-25-000076.md) | [51.5](/filings/0000842162-26-000038.md) | [50.8](/filings/0000842162-26-000068.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 49,324,764 at 2026-07-28, from the cover of the [10-Q filed 2026-07-31](/filings/0000842162-26-000068.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.